Innogen · News · November 30, 2010

Balancing Benefits and Risks of Synthetic Biology

DNA Helix

Heather Lowrie and Joyce Tait’s work used to develop recommendations by US Presidential Commission.

Heather Lowrie and Joyce Tait contributed to the development of a Concept Note on the ‘Risk Governance of Synthetic Biology’ for the International Risk Governance Council (IRCG) that has recently been used as background reading by the US Presidential Commission for the Study of Bioethical Issues (PCSBI).

The PCSBI is preparing recommendations for the President concerning synthetic biology, to be published by the end of the year.

Based on her work with the IRGC, Heather recently wrote an article on how the field of synthetic biology challenges the way we see our world. Published by the American Institute of Biological Science, ‘Balancing Benefits and Risks of Synthetic Biology’ suggests the need to consider the ethical and safety concerns of this new technology sooner than later and questions which approach is best to globally develop and manage this science safely.